Literature DB >> 18346862

Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes.

Katalin Jemnitz1, Zsuzsa Veres, Katalin Monostory, László Kóbori, László Vereczkey.   

Abstract

Most of the experiments studying acetaminophen (APAP) induced hepatotoxicity were performed using moue as model specie, right because its high sensitivity. While the toxic responses can be called forth easily in mice, the human relevancy of these results is questionable. In this study human, rat, and mouse primary hepatocytes were treated with increasing concentrations of APAP, and cell viability was measured by MTT cytotoxicity assay. Pronounced interspecies differences were obtained in cell viability following 24h of APAP treatment starting at 24h after seeding (EC50: 3.8mM, 7.6mM, and 28.2mM, in mouse, rat, and human hepatocyte culture, respectively). The longer time of culturing highly increased the resistance of hepatocytes of all species investigated. In rat hepatocyte culture EC50 values were 6.0mM, 12.5mM, and 18.8mM, when starting APAP treatment after 24, 48, and 72 h of seeding. Although N-acetylbenzoquinoneimine, a minor metabolite of APAP, which is mainly formed by CYP2E1 at high APAP concentration in every species studied, is thought to initiate the toxic processes, no correlation was found between CYP2E1 activities and hepatocyte sensitivity of different species. We conclude that the toxicity induced by APAP overdose highly depends on the animal model applied.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346862     DOI: 10.1016/j.tiv.2008.02.001

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  28 in total

1.  A microfluidic 3D hepatocyte chip for hepatotoxicity testing of nanoparticles.

Authors:  Lei Li; Kurtulus Gokduman; Aslihan Gokaltun; Martin L Yarmush; Osman Berk Usta
Journal:  Nanomedicine (Lond)       Date:  2019-06-10       Impact factor: 5.307

2.  Acetaminophen and NAPQI are toxic to auditory cells via oxidative and endoplasmic reticulum stress-dependent pathways.

Authors:  Gilda M Kalinec; Pru Thein; Arya Parsa; Joshua Yorgason; William Luxford; Raul Urrutia; Federico Kalinec
Journal:  Hear Res       Date:  2014-04-30       Impact factor: 3.208

3.  Ferroptosis is Involved in Acetaminophen Induced Cell Death.

Authors:  Tamás Lőrincz; Katalin Jemnitz; Tamás Kardon; József Mandl; András Szarka
Journal:  Pathol Oncol Res       Date:  2015-05-12       Impact factor: 3.201

4.  Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma.

Authors:  Ying-Jen Jeffrey Wu; Alexander J Neuwelt; Leslie L Muldoon; Edward A Neuwelt
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

5.  Acute exposure to ozone exacerbates acetaminophen-induced liver injury in mice.

Authors:  Daher Ibrahim Aibo; Neil P Birmingham; Ryan Lewandowski; Jane F Maddox; Robert A Roth; Patricia E Ganey; James G Wagner; Jack R Harkema
Journal:  Toxicol Sci       Date:  2010-02-01       Impact factor: 4.849

6.  Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro.

Authors:  A Dash; M B Simmers; T G Deering; D J Berry; R E Feaver; N E Hastings; T L Pruett; E L LeCluyse; B R Blackman; B R Wamhoff
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-13       Impact factor: 4.249

7.  Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice.

Authors:  Laura Zanobbio; Marco Palazzo; Silvia Gariboldi; Giuseppina F Dusio; Diego Cardani; Valentina Mauro; Fabrizio Marcucci; Andrea Balsari; Cristiano Rumio
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

8.  Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury.

Authors:  Linhao Li; Hongbing Wang; Jace W Jones
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-09-30       Impact factor: 3.072

9.  Using acetaminophen's toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines.

Authors:  Alexander J Neuwelt; Y Jeffrey Wu; Narcyz Knap; Marcin Losin; Edward A Neuwelt; Michael A Pagel; Steven Warmann; Joerg Fuchs; Piotr Czauderna; Michal Wozniak
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

Review 10.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.